Statistical table
Data point | Data structure | Type of test | 95% Confidence interval vs normal | 95% Confidence interval vs fluoxetine | 95% Confidence interval vs 1 week MD | 95% Confidence interval vs fluoxetine + 1 week MD |
---|---|---|---|---|---|---|
V1 Ipsi synapsin - Normal | Normal | Bootstrapping + Monte Carlo Simulation | 0.8112–1.1888 | 0.7825–1.2380 | 1.1441–0.8279 | 0.7813–0.9824 |
V1 Ipsi synapsin- fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | 0.8388–1.1612 | 0.8131–1.2074 | 1.1275–0.8445 | 0.7945–0.9692 |
V1 Ipsi synapsin - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8094–1.1906 | 0.7820–1.2384 | 1.1457–0.8263 | 0.7798–0.9839 |
V1 Ipsi synapsin - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8378–1.1622 | 0.8126–1.2079 | 1.1258–0.8462 | 0.7951–0.9686 |
V1 Ipsi synaptophysin - Normal | Normal | Bootstrapping + Monte Carlo Simulation | 0.8812–1.1188 | 0.8583–1.1757 | 0.9164–1.2347 | 0.9007–1.1095 |
V1 Ipsi synaptophysin - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | 0.8957–1.1043 | 0.8817–1.1523 | 0.9400–1.2110 | 0.9152–1.0950 |
V1 Ipsi synaptophysin - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8783–1.1217 | 0.8604–1.1735 | 0.9147–1.2364 | 0.9011–1.1091 |
V1 Ipsi synaptophysin - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8977–1.1023 | 0.8782–1.1558 | 0.9352–1.2159 | 0.9150–1.0953 |
V1 Ipsi PSD-95 – Normal | Normal | Bootstrapping + Monte Carlo Simulation | 0.6143–1.3857 | 0.7437–1.2262 | 1.0125–1.3042 | 0.9502–1.3776 |
V1 Ipsi PSD-95 - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | 0.6678–1.3322 | 0.7799–1.1900 | 1.0345–1.2823 | 0.9780–1.3498 |
V1 Ipsi PSD-95 - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.6117–1.3883 | 0.7469–1.2230 | 1.0125–1.3043 | 0.9499–1.3779 |
V1 Ipsi PSD-95 - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.6678–1.3322 | 0.7799–1.1900 | 1.0325–1.2843 | 0.9765–1.3513 |
V1 Ipsi gephyrin - Normal | Normal | Bootstrapping + Monte Carlo Simulation | 0.7124–1.2876 | 0.7326–1.2570 | 0.9003–1.1418 | 0.9795–1.2321 |
V1 Ipsi gephyrin - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | 0.7491–1.2509 | 0.7669–1.2228 | 0.9169–1.1253 | 0.9974–1.2142 |
V1 Ipsi gephyrin - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.7048–1.2952 | 0.7297–1.2599 | 0.9035–1.1386 | 0.9795–1.2320 |
V1 Ipsi gephyrin - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.7533–1.2467 | 0.7677–1.2219 | 0.9182–1.1239 | 0.9961–1.2155 |
V1 contra synapsin- normal | Normal | Bootstrapping + Monte Carlo Simulation | 0.8105–1.1895 | 0.7781–1.2424 | 0.5763–1.1335 | 0.7372–1.3212 |
V1 contra synapsin- fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | 0.8384–1.1616 | 0.8055–1.2150 | 0.6118–1.0979 | 0.7764–1.2820 |
V1 contra synapsin - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8138–1.1862 | 0.7726–1.2478 | 0.5732–1.1365 | 0.7322–1.3262 |
V1 contra synapsin - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8381–1.1619 | 0.8103–1.2102 | 0.6112–1.0986 | 0.7680–1.2904 |
V1 contra synaptophysin - normal | Normal | Bootstrapping + Monte Carlo Simulation | 0.8801–1.1199 | 0.8473–1.1555 | 0.7132–1.0231 | 0.8204–1.0900 |
V1 contra synaptophysin - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | 0.8777–1.1223 | 0.8663–1.1366 | 0.7315–1.0048 | 0.8387–1.0717 |
V1 contra synaptophysin - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8959–1.1041 | 0.8459–1.1569 | 0.7144–1.0219 | 0.8202–1.0902 |
V1 contra synaptophysin - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8930–1.1070 | 0.8693–1.1336 | 0.7350–1.0013 | 0.8389–1.0715 |
V1 contra VGLUT1 - normal | Normal | Bootstrapping + Monte Carlo Simulation | 0.8693–1.1307 | 0.6128–0.8079 | 1.0116–1.4828 | 0.7065–1.0228 |
V1 contra VGLUT1 - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | 0.8872–1.1128 | 0.6250–0.7957 | 1.0435–1.4509 | 0.7247–1.0046 |
V1 contra VGLUT1 - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8685–1.1315 | 0.6107–0.8100 | 1.0034–1.4910 | 0.7044–1.0249 |
V1 contra VGLUT1 - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8876–1.1124 | 0.6227–0.7980 | 1.0387–1.4557 | 0.7228–1.0065 |
V1 contra VGAT - normal | Normal | Bootstrapping + Monte Carlo Simulation | 0.6458–1.3542 | 0.5777–1.2580 | 0.6151–1.0278 | 0.6073–1.3463 |
V1 contra VGAT - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | 0.6993–1.3007 | 0.6330–1.2027 | 0.6390–1.0039 | 0.6511–1.3025 |
V1 contra VGAT - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.6512–1.3488 | 0.5808–1.2549 | 0.6160–1.0269 | 0.6015–1.3521 |
V1 contra VGAT - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.6956–1.3044 | 0.6339–1.2019 | 0.6414–1.0015 | 0.6515–1.3020 |
V1 contra PSD-95 - normal | Normal | Bootstrapping + Monte Carlo Simulation | 0.6038–1.3962 | 0.7218–1.1861 | 0.4462–0.8174 | 0.9084–2.0180 |
V1 contra PSD-95 - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | 0.6683–1.3317 | 0.7503–1.1575 | 0.4720–0.7916 | 0.9719–1.9545 |
V1 contra PSD-95 - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.6097–1.3903 | 0.7204–1.1875 | 0.4505–0.8131 | 0.9037–2.0227 |
V1 contra PSD-95 - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.6679–1.3321 | 0.7493–1.1585 | 0.4700–0.7937 | 0.9767–1.9497 |
V1 contra gephyrin - Normal | Normal | Bootstrapping + Monte Carlo Simulation | 0.7050–1.2950 | 0.7343–1.3432 | 0.4036–0.7036 | 0.8690–1.8151 |
V1 contra gephyrin - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | 0.7480–1.2520 | 0.7847–1.2928 | 0.4257–0.6815 | 0.9298–1.7543 |
V1 contra gephyrin - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.7089–1.2911 | 0.7444–1.3331 | 0.4053–0.7019 | 0.8845–1.7996 |
V1 contra gephyrin - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.7515–1.2485 | 0.7858–1.2916 | 0.4304–0.6768 | 0.9435–1.7406 |
V1 contra GluN1 - normal | Normal | Bootstrapping + Monte Carlo Simulation | 0.8909–1.1092 | 0.6978–1.0043 | 1.0128–1.4852 | 0.6713–0.9632 |
V1 contra GluN1 - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | 0.9037–1.0963 | 0.7187–0.9834 | 1.0445–1.4536 | 0.6910–0.9434 |
V1 contra GluN1 - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8910–1.1090 | 0.6980–1.0042 | 1.0159–1.4822 | 0.6696–0.9648 |
V1 contra GluN1 - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.9053–1.0947 | 0.7206–0.9815 | 1.0457–1.4523 | 0.6897–0.9447 |
V1 contra GluA2 - normal | Normal | Bootstrapping + Monte Carlo Simulation | 0.8632–1.1368 | 0.7766–1.0205 | 1.0076–1.3460 | 0.7128–0.9906 |
V1 contra GluA2 - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | 0.8824–1.1176 | 0.7943–1.0028 | 1.0326–1.3210 | 0.7128–0.9906 |
V1 contra GluA2 - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8605–1.1395 | 0.7774–1.0197 | 1.0017–1.3519 | 0.7368–0.9667 |
V1 contra GluA2 - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8790–1.1210 | 0.7940–1.0030 | 1.0316–1.3220 | 0.7310–0.9724 |
V1 contra GluN2A - normal | Normal | Bootstrapping + Monte Carlo Simulation | 0.7104–1.2896 | 0.6612–1.0471 | 0.9664–1.5040 | 0.7161–1.1003 |
V1 contra GluN2A - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | 0.7063–1.2937 | 0.6880–1.0203 | 1.0035–1.4669 | 0.7431–1.0733 |
V1 contra GluN2A - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.7430–1.2569 | 0.6628–1.0455 | 0.9607–1.5097 | 0.7190–1.0974 |
V1 contra GluN2A - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.7418–1.2582 | 0.6832–1.0251 | 1.0056–1.4648 | 0.7427–1.0737 |
V1 contra GluN2B - normal | Normal | Bootstrapping + Monte Carlo Simulation | 0.7772–1.2228 | 0.5712–0.8636 | 0.8007–1.1522 | 0.6562–0.9201 |
V1 contra GluN2B - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | 0.7812–1.2188 | 0.5881–0.8466 | 0.8229–1.1300 | 0.6740–0.9022 |
V1 contra GluN2B - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8074–1.1926 | 0.5659–0.8688 | 0.8029–1.1500 | 0.6584–0.9179 |
V1 contra GluN2B - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8120–1.1880 | 0.5862–0.8485 | 0.8239–1.1289 | 0.6728–0.9034 |
V1 contra GABAA3 - normal | Normal | Bootstrapping + Monte Carlo Simulation | 0.8712–1.1288 | 0.7659–1.0577 | 0.9939–1.3721 | 0.7512–1.0196 |
V1 contra GABAA3 - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | 0.8908–1.1092 | 0.7856–1.0380 | 1.0139–1.3520 | 0.7645–1.0063 |
V1 contra GABAA3 - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8729–1.1271 | 0.7641–1.0596 | 0.9921–1.3738 | 0.7447–1.0261 |
V1 contra GABAA3 - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8894–1.1106 | 0.7883–1.0353 | 1.0207–1.3452 | 0.7655–1.0053 |
V1 contra GABAA1 - normal | Normal | Bootstrapping + Monte Carlo Simulation | 0.8751–1.1249 | 0.8854–1.5893 | 0.7594–1.2798 | 0.5585–1.9208 |
V1 contra GABAA1 - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | 0.8898–1.1102 | 0.9302–1.5445 | 0.7971–1.2422 | 0.6434–1.8359 |
V1 contra GABAA1 - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8713–1.1287 | 0.8863–1.5883 | 0.7642–1.2751 | 0.5339–1.9454 |
V1 contra GABAA1 - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | 0.8883–1.1117 | 0.9312–1.5435 | 0.7932–1.2461 | 0.6465–1.8328 |
V1 contra GluA2–GluN1 - normal | Normal | Bootstrapping + Monte Carlo Simulation | –0.0675 to 0.0603 | –0.0351 to 0.0859 | –0.0838 to 0.0295 | –0.0379 to 0.0676 |
V1 contra GluA2–GluN1 – fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | –0.0595 to 0.0523 | –0.0279 to 0.0787 | –0.0766 to 0.0223 | –0.0304 to 0.0601 |
V1 contra GluA2–GluN1 - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | –0.0675 to 0.0603 | –0.0360 to 0.0868 | –0.0834 to 0.0291 | –0.0370 to 0.0667 |
V1 contra GluA2–GluN1 - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | –0.0596 to 0.0525 | –0.0270 to 0.0778 | –0.0774 to 0.0231 | –0.0317 to 0.0614 |
V1 contra GluN2A–GluN2B – Normal | Normal | Bootstrapping + Monte Carlo Simulation | –0.1879 to 0.0107 | –0.0659 to 0.0841 | –0.0451 to 0.1269 | –0.0775 to 0.0616 |
V1 contra GluN2A–GluN2B – fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | –0.1755 to –0.0018 | –0.0553 to 0.0735 | –0.0331–0.1149 | –0.0694 to 0.0536 |
V1 contra GluN2A–GluN2B - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | –0.1862 to 0.0090 | –0.0679 to 0.0862 | –0.0456 to 0.1274 | –0.0767 to 0.0608 |
V1 contra GluN2A–GluN2B - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | –0.1738 to –0.0034 | –0.0569 to 0.0752 | –0.0347 to 0.1165 | –0.0684 to 0.0526 |
V1 contra GABAA1–GABAA3 - Normal | Normal | Bootstrapping + Monte Carlo Simulation | –0.1582 to 0.0079 | –0.0817 to 0.1848 | –0.2900 to –0.0325 | –0.1058 to 0.1577 |
V1 contra GABAA1:GABAA3 - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | –0.1463 to –0.0039 | –0.0619 to 0.1650 | –0.2744 to –0.0481 | –0.0873 to 0.1392 |
V1 contra GABAA1:GABAA3 - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | –0.1594 to 0.0092 | –0.0804 to 0.1835 | –0.2919 to –0.0306 | –0.1062 to 0.1582 |
V1 contra GABAA1:GABAA3 - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | –0.1472 to –0.0031 | –0.0610 to 0.1641 | –0.2729 to –0.0496 | –0.0866 to 0.1385 |
V1 contra Presynaptic E/I - Normal | Normal | Bootstrapping + Monte Carlo Simulation | –0.0981 to 0.1807 | –0.2242 to 0.0731 | 0.0853–0.3517 | –0.1710 to 0.1301 |
V1 contra Presynaptic E/I - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | –0.0809 to 0.1635 | –0.2033 to 0.0523 | 0.1032–0.3338 | –0.1525 to 0.1116 |
V1 contra Presynaptic E/I - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | –0.0983 to 0.1808 | –0.2288 to 0.0777 | 0.0850–0.3520 | –0.1725 to 0.1316 |
V1 contra Presynaptic E/I - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | –0.0770 to 0.1595 | –0.2074 to 0.0563 | 0.0987–0.3383 | –0.1521 to 0.1112 |
V1 contra Postsynaptic E/I - Normal | Normal | Bootstrapping + Monte Carlo Simulation | –0.1202 to 0.1499 | –0.1150 to 0.0745 | 0.0653–0.3197 | –0.0334 to 0.1542 |
V1 contra Postsynaptic E/I - fluoxetine | Normal | Bootstrapping + Monte Carlo Simulation | –0.0999 to 0.1295 | –0.1009 to 0.0604 | 0.0834–0.3016 | –0.0208 to 0.1417 |
V1 contra Postsynaptic E/I - 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | –0.1199 to 0.1495 | –0.1155 to 0.0750 | 0.0629–0.3221 | –0.0324 to 0.1532 |
V1 contra Postsynaptic E/I - fluoxetine + 1 week MD | Normal | Bootstrapping + Monte Carlo Simulation | –0.1008 to 0.1304 | –0.1021 to 0.0616 | 0.0818–0.3032 | –0.0210 to 0.1418 |